BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29039686)

  • 1. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.
    Clarke DF; Penazzato M; Capparelli E; Cressey TR; Siberry G; Sugandhi N; Mirochnick M;
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):83-93. PubMed ID: 29039686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.
    Ruel TD; Capparelli EV; Tierney C; Nelson BS; Coletti A; Bryson Y; Cotton MF; Spector SA; Mirochnick M; LeBlanc R; Reding C; Zimmer B; Persaud D; Bwakura-Dangarembizi M; Naidoo KL; Hazra R; Jean-Philippe P; Chadwick EG
    Lancet HIV; 2021 Mar; 8(3):e149-e157. PubMed ID: 33242457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral treatment for children with peripartum nevirapine exposure.
    Palumbo P; Lindsey JC; Hughes MD; Cotton MF; Bobat R; Meyers T; Bwakura-Dangarembizi M; Chi BH; Musoke P; Kamthunzi P; Schimana W; Purdue L; Eshleman SH; Abrams EJ; Millar L; Petzold E; Mofenson LM; Jean-Philippe P; Violari A
    N Engl J Med; 2010 Oct; 363(16):1510-20. PubMed ID: 20942667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to antiretrovirals in HIV-infected pregnant women.
    Weinberg A; Forster-Harwood J; McFarland EJ; Pappas J; Davies JK; Kinzie K; Barr EA; Paul SM; Salbenblatt CR; Soda E; Vazquez A; Levin MJ
    J Clin Virol; 2009 May; 45(1):39-42. PubMed ID: 19329355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.
    Nolan M; Fowler MG; Mofenson LM
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):216-29. PubMed ID: 12045685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement.
    Eke AC; Olagunju A; Momper J; Penazzato M; Abrams EJ; Best BM; Capparelli EV; Bekker A; Belew Y; Kiser JJ; Struble K; Taylor G; Waitt C; Mirochnick M; Cressey TR; Colbers A;
    Clin Pharmacol Ther; 2021 Jul; 110(1):36-48. PubMed ID: 32930408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral pharmacology in pregnant women and their newborns.
    Mirochnick M
    Ann N Y Acad Sci; 2000 Nov; 918():287-97. PubMed ID: 11131716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.
    Palombi L; Nielsen-Saines K; Giuliano M; Marazzi MC
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):807-8. PubMed ID: 21142813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of perinatal HIV.
    Capparelli E; Rakhmanina N; Mirochnick M
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):161-75. PubMed ID: 15701581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.